ZA200709924B - Polypeptides - Google Patents

Polypeptides

Info

Publication number
ZA200709924B
ZA200709924B ZA200709924A ZA200709924A ZA200709924B ZA 200709924 B ZA200709924 B ZA 200709924B ZA 200709924 A ZA200709924 A ZA 200709924A ZA 200709924 A ZA200709924 A ZA 200709924A ZA 200709924 B ZA200709924 B ZA 200709924B
Authority
ZA
South Africa
Prior art keywords
pmhc
ilt
polypeptide
given class
affinity
Prior art date
Application number
ZA200709924A
Other languages
English (en)
Inventor
Jakobsen Bent Karsten
Li Yi
Moysey Ruth Karen
Original Assignee
Medigene Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medigene Ltd filed Critical Medigene Ltd
Publication of ZA200709924B publication Critical patent/ZA200709924B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/70535Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA200709924A 2005-05-25 2007-11-16 Polypeptides ZA200709924B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0510627.3A GB0510627D0 (en) 2005-05-25 2005-05-25 Polypeptides

Publications (1)

Publication Number Publication Date
ZA200709924B true ZA200709924B (en) 2009-03-25

Family

ID=34834594

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200709924A ZA200709924B (en) 2005-05-25 2007-11-16 Polypeptides

Country Status (15)

Country Link
US (1) US8092807B2 (de)
EP (1) EP1885752B1 (de)
JP (1) JP2008545404A (de)
CN (1) CN101268100A (de)
AT (1) ATE473240T1 (de)
AU (1) AU2006250976A1 (de)
BR (1) BRPI0611167A2 (de)
CA (1) CA2609447A1 (de)
DE (1) DE602006015306D1 (de)
EA (1) EA200702609A1 (de)
ES (1) ES2348674T3 (de)
GB (1) GB0510627D0 (de)
MX (1) MX2007014585A (de)
WO (1) WO2006125963A2 (de)
ZA (1) ZA200709924B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0623539D0 (en) * 2006-11-24 2007-01-03 Avidex Ltd Polypeptides
EP2084184A1 (de) 2006-11-24 2009-08-05 Medigene Limited Ilt-2-(liri-)varianten mit erhöhter affinität für mhc-klasse-i-moleküle
WO2009060159A1 (en) * 2007-11-08 2009-05-14 Medigene Limited Mutated ilt molecules

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2161338A1 (de) 1996-12-06 2010-03-10 Schering Corporation Isolierte Säugetier-Monozytzellgene, zugehörige Reagenzien
US6384203B1 (en) 1999-05-12 2002-05-07 Immunex Corporation Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
US6448035B1 (en) 1997-04-24 2002-09-10 Immunex Corporation Family of immunoregulators designated leukocyte immunoglobulin-like receptor (LIR)
GB9722779D0 (en) 1997-10-28 1997-12-24 Isis Innovation Human CD8 as an inhibitor of the cellular immune system
IL139344A0 (en) 1998-05-19 2001-11-25 Avidex Ltd Soluble t cell receptor
JP2004524001A (ja) 2000-01-25 2004-08-12 ハイセック,インコーポレーテッド 白血球免疫グロブリン受容体(lir様)ポリペプチドおよびポリヌクレオチドに関する方法と材料
AU2002360376B2 (en) 2001-11-14 2006-05-18 Immunex Corporation Modulation of LIR function to treat rheumatoid arthritis
EP1578367A4 (de) 2002-11-01 2012-05-02 Genentech Inc Zusammensetzungen und verfahren zur behandlung von immunerkrankungen
WO2005058953A2 (en) 2003-12-12 2005-06-30 Regeneron Pharmaceuticals, Inc. Ogh fusion polypeptides and therapeutic uses thereof
AU2005207960A1 (en) 2004-01-28 2005-08-11 Syntonix Pharmaceuticals, Inc. Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for the treatment of infertility
GB0411773D0 (en) * 2004-05-26 2004-06-30 Avidex Ltd Method for the identification of polypeptides which bind to a given peptide mhc complex or cd 1-antigen complex
WO2006033811A2 (en) 2004-09-03 2006-03-30 The Trustees Of Columbia University In The City Of New York Ilt3 polypeptides and uses thereof
EP2084184A1 (de) 2006-11-24 2009-08-05 Medigene Limited Ilt-2-(liri-)varianten mit erhöhter affinität für mhc-klasse-i-moleküle

Also Published As

Publication number Publication date
WO2006125963A3 (en) 2008-04-17
WO2006125963A2 (en) 2006-11-30
GB0510627D0 (en) 2005-06-29
EP1885752A2 (de) 2008-02-13
CA2609447A1 (en) 2006-11-30
US20090208447A1 (en) 2009-08-20
US8092807B2 (en) 2012-01-10
MX2007014585A (es) 2008-04-22
CN101268100A (zh) 2008-09-17
EA200702609A1 (ru) 2008-10-30
ATE473240T1 (de) 2010-07-15
JP2008545404A (ja) 2008-12-18
ES2348674T3 (es) 2010-12-10
BRPI0611167A2 (pt) 2010-08-17
AU2006250976A1 (en) 2006-11-30
DE602006015306D1 (de) 2010-08-19
EP1885752B1 (de) 2010-07-07

Similar Documents

Publication Publication Date Title
AU2013205271B2 (en) Human CGRP receptor binding proteins
CY1117476T1 (el) Ανταγωνιστες συμπληρωματων και οι χρησεις αυτων
EP2447280A3 (de) VEGF Analoga und Verfahren zur Verwendung davon
EA200601738A1 (ru) Модифицированные белки буганины, цитотоксины и способы их применения
EP3118218A3 (de) Fusionsproteine zur verabreichung in die blut-hirn-schranke
AR113422A2 (es) Agentes tensioactivos reconstituidos que tienen propiedades mejoradas
ATE529442T1 (de) Verbesserte humane interferon-moleküle und ihre verwendungen
EP3311833A3 (de) Zusammensetzungen zur induzierung von t-zellen-hilfe
WO2009061853A3 (en) Mutant interleukin-2 (il-2) polypeptides
WO2006020060A3 (en) Iap binding compounds
EP2719708A3 (de) Material und Verfahren zur Behandlung oder Vorbeugung von HER-3-assoziierten Erkrankungen
EP3670536A3 (de) Rekombinante polypeptidmitglieder der tnf-liganden-familien mit antikörperbindender domäne und verwendungen dafür
UA98295C2 (ru) Опухолево-ассоциированный пептид, который неспецифически связывается с молекулами ii класса лейкоцитарного антигена человека (hla)
WO2006037106A3 (en) Carboxy-amido-triazoles for the localized treatment of ocular diseases
WO2007073509A3 (en) Modified annexin proteins and methods for their use in organ transplantation
MX2010011957A (es) Moleculas de union basadas en fibronectina mejoradas y usos de las mismas.
MX2008004734A (es) Composicion rica en leucina.
WO2007044809A3 (en) Albumin-free botulinum toxin based pharmaceutical compositions containing a hyaluronidase and methods of use
WO2009004315A8 (en) Isolated peptides and uses thereof
GB0524477D0 (en) Isolated T cell receptors which specifically bind to vygfvracl-hla-24
RS52802B (en) USE OF PEPTIDS RELATING TO TPO RECEPTOR
MX2009002787A (es) Composiciones y métodos para prevenir el cáncer con cupredoxinas.
EP2510941A3 (de) Verfahren zur Behandlung von multipler Sklerose mittels Verabreichung eines alpha-Fetoproteins in Kombination mit einem Integrinantagonisten
WO2009047513A3 (en) Antagonists of kisspeptin and uses thereof
ZA200709924B (en) Polypeptides